Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E17.42 EPS (ttm)12.77 Insider Own0.20% Shs Outstand590.00M Perf Week-4.63%
Market Cap131.22B Forward P/E13.11 EPS next Y16.96 Insider Trans-1.02% Shs Float586.72M Perf Month-5.87%
Income7.68B PEG2.93 EPS next Q3.83 Inst Own78.10% Short Float1.34% Perf Quarter5.71%
Sales23.97B P/S5.48 EPS this Y2.00% Inst Trans-1.33% Short Ratio2.25 Perf Half Y-2.38%
Book/sh16.08 P/B13.83 EPS next Y8.95% ROA12.80% Target Price252.21 Perf Year29.85%
Cash/sh13.58 P/C16.38 EPS next 5Y5.95% ROE75.10% 52W Range166.68 - 244.99 Perf YTD-7.74%
Dividend6.40 P/FCF25.03 EPS past 5Y14.00% ROI21.20% 52W High-9.22% Beta0.97
Dividend %2.88% Quick Ratio1.30 Sales past 5Y3.10% Gross Margin79.90% 52W Low33.43% ATR6.71
Employees23400 Current Ratio1.60 Sales Q/Q10.90% Oper. Margin39.90% RSI (14)43.99 Volatility2.21% 2.91%
OptionableYes Debt/Eq3.36 EPS Q/Q-3.40% Profit Margin32.00% Rel Volume0.68 Prev Close226.43
ShortableYes LT Debt/Eq3.16 EarningsApr 30 AMC Payout46.30% Avg Volume3.50M Price222.40
Recom2.20 SMA20-5.21% SMA500.72% SMA2002.20% Volume2,397,794 Change-1.78%
Apr-15-20Resumed Guggenheim Neutral
Mar-31-20Initiated Wolfe Research Peer Perform
Mar-30-20Upgrade Raymond James Mkt Perform → Outperform $255
Mar-05-20Upgrade BofA/Merrill Neutral → Buy $245 → $250
Feb-27-20Initiated Barclays Equal Weight $235
Jan-31-20Downgrade Robert W. Baird Neutral → Underperform $173 → $185
Jan-21-20Upgrade Evercore ISI In-line → Outperform
Dec-24-19Initiated Raymond James Mkt Perform
Dec-17-19Resumed Morgan Stanley Overweight $280
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
May-26-20 05:00PM  Amgen To Webcast Investor Meeting At 56th Annual Meeting Of The American Society Of Clinical Oncology (ASCO) PR Newswire
07:52AM  Coronavirus Vaccine Development Gathers Steam: 4 Winners Zacks
May-20-20 07:00PM  Amgen Announces Voting Results Of Annual Meeting Of Stockholders PR Newswire
May-19-20 08:03AM  5 Biotech Stocks in Focus as Race for Coronavirus Vaccine Heats Up Zacks
08:00AM  Biotech Giant Amgen Is Nearing A Breakout, But Is AMGN Stock A Buy? Investor's Business Daily
May-18-20 03:37PM  We could still see a V-Shaped recovery: Expert Yahoo Finance Video
12:00PM  Amgen (AMGN) Upgraded to Buy: What Does It Mean for the Stock? Zacks
May-14-20 10:46AM  Merck, Roche, Amgen Stocks React to Release of Cancer-Drug Data Barrons.com
06:42AM  Earnings season shows how fast companies have upped their digital game, says Goldman MarketWatch
May-13-20 03:45PM  Dow Jones Slides 1,171 Points In 3 Days After Fed Chair Speech Sharpens Recession Fear Investor's Business Daily
06:32AM  Is Now Still a Good Time To Buy Amgen? Motley Fool
May-12-20 01:36PM  The Zacks Analyst Blog Highlights: Amgen, BHP, Altria, Apple and Target Zacks
09:00AM  Amgen To Present At The Bank Of America Merrill Lynch Virtual Global Healthcare Conference PR Newswire
May-11-20 01:23PM  Top Research Reports for Amgen, BHP, Altria & Others Zacks
12:15PM  Biotech Stock Rally Is Crushing Short Sellers Benzinga
09:07AM  Why Amgen Soared in April Motley Fool
May-10-20 08:04AM  Should You Buy Amgen Inc. (NASDAQ:AMGN) For Its Upcoming Dividend In 4 Days? Simply Wall St.
May-08-20 04:24PM  Are Biotech ETFs in Trouble as Coronavirus Dims Guidance? Zacks
11:23AM  5 Biopharmas Where BofA Would Put Its Money To Work Benzinga
08:30AM  FDA Grants Fast Track Designation for Omecamtiv Mecarbil in Heart Failure GlobeNewswire
08:30AM  FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure PR Newswire
May-07-20 11:24AM  Akebia Shares Climb on Positive Anemia Drug Study Results GuruFocus.com
May-06-20 03:06PM  Coronavirus update: U.S. death toll tops 71,000, as Trump backs off plan to wind down pandemic task force MarketWatch
02:50PM  These 23 companies are working on coronavirus treatments or vaccines heres where things stand MarketWatch
09:00AM  Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 ADVANCE Study In Mild-To-Moderate Plaque Psoriasis PR Newswire
08:19AM  Adaptive, Microsoft to conduct study evaluating T-cells in COVID-19 patients MarketWatch
May-05-20 03:26PM  Coronavirus U.S. death toll may hit 134k+ by early August, study reveals Yahoo Finance Video
11:50AM  Why Akebia Therapeutics Stock Is Crushing It Today Motley Fool
09:00AM  KYPROLIS® (carfilzomib) Patents Upheld Against Generic Manufacturer PR Newswire
07:21AM  Akebia's shares jump on late-stage clinical trial results for kidney disease drug MarketWatch
May-04-20 05:59PM  Cytokinetics Trading at Half High Target of $30 GuruFocus.com
05:15PM  Apple borrows $8.5 billion, joins record corporate debt borrowing spree MarketWatch
04:08PM  Treasury yields come off lows as investors fixate on corporate and government debt sales MarketWatch
03:12PM  Trump expresses confidence for coronavirus vaccine by the end of the year Yahoo Finance Video
10:15AM  Amgen Inc. -- Moody's assigns Baa1 rating to Amgen's new sr. unsecured notes; stable outlook Moody's
May-03-20 08:19AM  Amgen Inc. (NASDAQ:AMGN) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year Simply Wall St.
May-01-20 10:44PM  Edited Transcript of AMGN earnings conference call or presentation 30-Apr-20 9:30pm GMT Thomson Reuters StreetEvents
06:28PM  U.S. Cases Increase 4.4%; Gilead Drug Gets FDA Nod: Virus Update Bloomberg
11:13AM  U.S. Cases Increase 1.2%, Slowest Pace This Month: Virus Update Bloomberg
10:54AM  Amgen (AMGN) Q1 Earnings Top, to Study Otezla for Coronavirus Zacks
08:09AM  Dow Jones Futures: Apple, Amazon, Trump Tariff Threat Pressure Coronavirus Stock Market Rally Investor's Business Daily
12:31AM  Amgen Inc (AMGN) Q1 2020 Earnings Call Transcript Motley Fool
Apr-30-20 05:58PM  Amazon Misses on Earnings, Apple Beats but Trades Lower Zacks
05:31PM  Amgen Stock Jumps on Earnings, Covid-19 Trial Announcement Barrons.com
05:25PM  Amgen (AMGN) Q1 Earnings and Revenues Surpass Estimates Zacks
05:21PM  Amgen Slips On New Plan To Battle Coronavirus As Quarterly Earnings Beat Investor's Business Daily
04:12PM  Amgen stock ticks higher after earnings beat MarketWatch
04:06PM  Amgen studying Otezla for coronavirus, looking into other treatments Reuters
04:06PM  Amgen studying Otezla for coronavirus, first-quarter results beat Street estimates Reuters
03:30PM  Amgen, Inc. to Host Earnings Call ACCESSWIRE
08:51AM  Remdesivir Progresses on Coronavirus Trial: Pharma Upbeat Zacks
Apr-29-20 10:05AM  Biotech Stocks Earnings Roster for Apr 30: AMGN, GILD & More Zacks
Apr-28-20 12:33PM  Tracking Q2 and Full-Year 2020 Earnings Estimates Zacks
11:18AM  Amgen (AMGN) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-27-20 04:01PM  Amgen Announces Webcast Of 2020 First Quarter Financial Results PR Newswire
12:43PM  Amgen Looks Set to Soar to New Heights - Despite the Naysayers TheStreet.com
Apr-24-20 01:33PM  Were Hedge Funds Right About Amgen, Inc. (AMGN)? Insider Monkey
11:30AM  The Week in Covid-19: A Second Peak Is Coming Bloomberg
Apr-23-20 03:26PM  21% tested positive for coronavirus antibodies in NYC, Cuomo says Yahoo Finance Video
01:55PM  'We're going to be in a lot of trouble' if we roll back coronavirus restrictions: Johns Hopkins doctor Yahoo Finance
01:40PM  Biotech giant Amgen signs big expansion deal in Tampa's Westshore business district American City Business Journals
12:32PM  Amgen (AMGN) Earnings Expected to Grow: Should You Buy? Zacks
06:06AM  Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 24%? Simply Wall St.
Apr-22-20 11:29AM  Icelandic Genomes Elucidate Neanderthal Heritage of Europeans CNW Group
10:55AM  Healthcare ETFs Looks Strong Ahead of Q1 Earnings Zacks
Apr-21-20 04:21PM  Why Vertex Stock Is The 'Most Insulated Name' Heading Into Earnings Investor's Business Daily
04:19PM  How A Short-Seller's Damning Report Sent This Cancer Biotech Tumbling Investor's Business Daily
07:05AM  City of Tampas relief fund hits capacity after day and a half, draws 10,000 inquiries American City Business Journals
Apr-20-20 10:40AM  Biotech ETF (BBH) Hits New 52-Week High Zacks
08:15AM  Gilead Increases Enrollment Target, Pharma Rally Continues Zacks
08:00AM  Why The Coronavirus Won't Shake Biotechs From Investing In China Investor's Business Daily
05:44AM  If You Had Invested Right After Amgen's IPO (AMGN) Investopedia
Apr-17-20 04:04PM  Obama's Surgeon General: Coronavirus response is 'nowhere near where it needs to be' Yahoo Finance Video
12:40PM  4 Healthcare Stocks to Buy For Coronavirus Innovation InvestorPlace
11:24AM  5 Stock Picks from the Hedge Fund Manager Who Saw The Pandemic Coming Insider Monkey
10:43AM  U.S., European health agencies to partner drugmakers in coronavirus fight Reuters
07:15AM  Gilead Brings Likely Coronavirus Cure, Pharma Rallies on R&D Zacks
Apr-16-20 11:18AM  The Zacks Analyst Blog Highlights: Microsoft, Walmart, Amgen, salesforce.com and Mondelez International Zacks
11:15AM  The Zacks Analyst Blog Highlights: Cardinal Health, Enphase Energy, Netflix, Amgen and Costco Wholesale Zacks
07:08AM  Amgen Stock Rises 3% Investing.com
Apr-15-20 05:06PM  Top Stock Reports for Microsoft, Walmart & Amgen Zacks
11:32AM  Industries That Thrive During Recessions Investopedia
10:07AM  4 GARP Stocks to Scoop Up for Maximum Returns Zacks
08:52AM  6 Recession-Proof Picks Amid Coronavirus-Led "The Great Lockdown" Zacks
08:26AM  Pharma Stocks Rally on Sanofi, GSK Coronavirus Vaccine Tie-Up Zacks
07:22AM  Amgen Stock Falls 3% Investing.com
Apr-14-20 05:21PM  Iceland Provides a Picture of the Early Spread of COVID-19 in a Population with a Cohesive Public Health Response PR Newswire
05:00PM  Iceland Provides a Picture of the Early Spread of COVID-19 in a Population With a Cohesive Public Health Response CNW Group
07:04AM  Amgen Stock Rises 3% Investing.com
Apr-08-20 10:39AM  Amgen Stock Rises 3% Investing.com
10:05AM  Biotech Stock Roundup: AMGN & INCY Focus on Coronavirus Treatments, & More Zacks
Apr-07-20 08:35PM  Amgen And Adaptive Biotechnologies To Participate In Webinar On COVID-19 Strategic Collaboration PR Newswire
Apr-06-20 06:39AM  Amgen Stock Rises 3% Investing.com
Apr-05-20 04:56PM  U.K. Prime Minister Boris Johnson Admitted to Hospital with Persistent Coronavirus Symptoms Barrons.com
10:14AM  With gowns and masks in short supply, researchers test drugs to prevent COVID-19 infections in health care workers MarketWatch
Apr-03-20 06:58PM  Video: 4 Large-Cap Stocks With Strong Buffett-Munger Characteristics GuruFocus.com
10:51AM  Pharma Coronavirus Efforts Continue, Amgen & Incyte Join In Zacks
Apr-02-20 07:58PM  Adaptive, Amgen collaborate on development of COVID-19 treatment American City Business Journals +5.60%
05:50PM  Covid Report: Amgen Pops As Heavyweight Biotech Enters Coronavirus Ring Investor's Business Daily
04:23PM  Biotech Amgen, Adaptive Tech Join Forces on New Coronavirus Drug SmarterAnalyst
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorMay 20Option Exercise54.691,00054,69016,482May 20 09:24 PM
SUGAR RONALD DDirectorMay 20Sale229.271,000229,27015,482May 20 09:24 PM
Williams R SandersDirectorMay 06Sale237.31425100,8575,409May 07 08:49 PM
SUGAR RONALD DDirectorApr 22Option Exercise54.691,00054,69015,636Apr 22 07:07 PM
SUGAR RONALD DDirectorApr 22Sale233.351,000233,35014,636Apr 22 07:07 PM
Bradway Robert AChairman, CEO and PresidentApr 13Option Exercise58.43127,0007,420,610595,516Apr 13 07:54 PM
Piacquad DavidSVP, Business DevelopmentFeb 06Sale229.939,2642,130,07939,700Feb 07 08:25 PM
Williams R SandersDirectorFeb 06Sale233.7242599,3314,988Feb 10 09:33 PM
Meline David WEVP & CFONov 25Sale234.368,7372,047,60349,378Nov 25 06:27 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 22Sale230.549,0002,074,83742,853Nov 25 06:25 PM
Piacquad DavidSVP, Business DevelopmentNov 20Option Exercise156.355,749898,85653,361Nov 20 08:09 PM
SUGAR RONALD DDirectorNov 06Option Exercise54.712,000109,42016,436Nov 07 06:20 PM
Williams R SandersDirectorNov 06Sale215.4542591,5665,413Nov 07 06:22 PM
SUGAR RONALD DDirectorNov 06Sale215.452,000430,90014,436Nov 07 06:20 PM
SUGAR RONALD DDirectorOct 02Option Exercise54.712,000109,42016,436Oct 03 05:06 PM
SUGAR RONALD DDirectorOct 02Sale193.582,000387,16014,436Oct 03 05:06 PM
SUGAR RONALD DDirectorSep 04Option Exercise54.712,000109,42016,336Sep 04 06:08 PM
SUGAR RONALD DDirectorSep 04Sale206.702,000413,40014,336Sep 04 06:08 PM
Patton Cynthia MSVP & CCOAug 30Option Exercise158.438,6241,366,33132,648Sep 04 06:07 PM
Patton Cynthia MSVP & CCOAug 30Sale208.0713,4262,793,51022,097Sep 04 06:07 PM
SUGAR RONALD DDirectorAug 07Option Exercise54.712,000109,42016,336Aug 08 07:09 PM
Williams R SandersDirectorAug 07Sale183.0442577,7925,838Aug 08 07:12 PM
SUGAR RONALD DDirectorAug 07Sale183.042,000366,08014,336Aug 08 07:09 PM
SUGAR RONALD DDirectorJul 03Option Exercise54.712,000109,42016,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJul 03Sale187.582,000375,16014,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJun 05Option Exercise54.712,000109,42016,219Jun 05 06:55 PM
SUGAR RONALD DDirectorJun 05Sale175.682,000351,36014,219Jun 05 06:55 PM